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Attempts have been made to use glycogen synthase kinase-3 beta (GSK3β) inhibitors for
prophylactic treatment of neurocognitive conditions. However the use of lithium, a non-
specific inhibitor of GSK3β results in mild cognitive impairment in humans. The effects of
global GSK3β inhibition or knockout on learning and memory in healthy adult mice are
also inconclusive. Our study aims to better understand the role of GSK3β in learning and
memory through a more regionally, targeted approach, specifically performing lentiviral-
mediated knockdown of GSK3βwithin the dentate gyrus (DG). DG-GSK3β-silenced mice
showed impaired contextual fear memory retrieval. However, cue fear memory, spatial
memory, locomotor activity and anxiety levels were similar to control. These GSK3β-
silenced mice also showed increased induction and maintenance of DG long-term
potentiation (DG-LTP) compared to control animals. Thus, this region-specific, targeted
knockdown of GSK3β in the DG provides better understanding on the role of GSK3β in
learning and memory.
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Introduction
Glycogen synthase kinase 3-beta (GSK3β) is a constitutively active serine protein kinase highly
expressed in the brain (Woodgett, 1990). Known targets of GSK3β number over 100, many of
which are involved in pathways related to cell growth, apoptosis, metabolism, learning andmemory
among others (Kaidanovich-Beilin and Woodgett, 2011). GSK3β’s kinase activity is positively
regulated by phosphorylation on its tyrosine 216 residue, or inhibited by phosphorylation on
its serine 9 residue (Wang et al., 1994). Lithium, a known GSK3 inhibitor was demonstrated
to inhibit GSK3β by increasing phosphorylation on the key serine residue (Ser9) (Jope, 2003).
It was shown that administration of lithium or another GSK3 inhibitor, AR-A014418 (ARA)
was able to improve cognitive performance in mouse models of neurocognitive conditions
such as Down’s syndrome and Fragile X syndrome or Alzheimer’s disease (AD) respectively
(Yuskaitis et al., 2010; Contestabile et al., 2013; Ly et al., 2013). GSK3 inhibition has thus been
suggested as a means of prophylactic treatment for human patients with these neurological
disorders (Licastro et al., 1983; Terao et al., 2006; Nunes et al., 2007; Liu and Smith, 2014).
However, there are also reports showing that lithium treatment increases the risk of dementia
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(Dunn et al., 2005) and also resulted in impairments in cognitive
performance of healthy individuals (Weingartner et al., 1985; Stip
et al., 2000; Wingo et al., 2009). These inconsistent outcomes
from pharmacological inhibition of GSK3 activity suggest that a
more specific approach through gene targeting of selected brain
regions may provide a better understanding on the function of
GSK3β in cognitive functions.
Overexpression or knock-in studies in healthy mice where
GSK3β is constitutively active showed spatial learning deficits
(Hernández et al., 2002), impairments in novel object and
inhibitory avoidance tests (Dewachter et al., 2009) and an
increase in fear memory retention (Polter et al., 2010). However,
results from inhibitor and transgenic knockout studies in
healthy rodents are controversial. Many GSK3 inhibitors
are also known to affect signaling cascades independent of
GSK3 (Meijer et al., 2004). Studies administering lithium,
a non-specific GSK3β inhibitor, mostly showed no effects
in healthy mice (King et al., 2014). Mice administered
with the GSK3β inhibitors valproic acid (Sintoni et al.,
2013) and SB 216763 (Hu et al., 2009; Sintoni et al.,
2013), showed impairments in the Morris water maze
task and contextual fear memory consolidation but not
reconsolidation in healthy mice. Heterozygous GSK3β
knockout mice and mice treated with ARA showed impaired
long term spatial memory and contextual fear memory
reconsolidation but these mice exhibit normal contextual
consolidation (Kimura et al., 2008). These discrepancies
may be due to confounding factors which include toxicity
from long term inhibitor administration, inhibitor non-
specificity, non-site specific inhibitor effects and in the case
of transgenic animals, aberrations caused by the reduction
of GSK3β during brain development which are carried into
adulthood.
Our study aims to further the understanding on the role
of GSK3β in learning and memory and synaptic plasticity by
genetically manipulating GSK3β levels specifically in the dentate
gyrus (DG) of young adult mice. The DG was chosen as the
target region for investigation as it is important for various
forms of learning andmemory, such as object discrimination and
contextual fear memory (both for context memory) as well as
Morris water maze (spatial memory; Rubin et al., 1999; Jeltsch
et al., 2001; Lee and Kesner, 2004; Nakashiba et al., 2012).
Materials and Methods
Animals
All animal procedures and applicable regulations of animal
welfare were performed in accordance with the GSK Policy
on the Care, Welfare and Treatment of Laboratory Animals
and also in accordance with Institutional Animal Care and Use
Committee (IACUC) guidelines and approved by SingHealth
IACUC, Singapore. Six to eight week old, male, C57BL/6 mice
(of 24–28 g) were purchased through SingHealth Experimental
Medicine Centre (SEMC), Singapore, and housed in Specific
Pathogen Free (SPF) animal facility at Duke-NUS Graduate
Medical School, Singapore. Food and water were provided to the
animals ad libitum.
Creation of Viral Vector
FUGW plasmid (Addgene) used for the creation of lentivirus
was modified to express shRNA sequences under the control of
U6 promoter and GFP under the control of human ubiquitin C
promoter. Shorthairpin (shRNA) against mouse and rat GSK3β:
CATGAAAGTTAGCAGAGAT (shGSK3) (Kim et al., 2006)
or scrambled control sequence: TTATCAGATAGACGATTGT
(shCon) (Ma et al., 2015) was cloned into the FUGW plasmid.
FUGW plasmid was co-transfected with HIV-1 packaging
vector Delta8.9 and the VSVG envelope glycoprotein
into human embryonic kidney (HEK) 293 gp cells to
produce viral particles. Growth medium was collected and
subjected to ultracentrifugation at 28,000 g for 90 min to
pellet viral particles. The viral pellet was re-suspended in
sterile PBS and viral titre determined by infecting HEK
293 cells with serial dilutions of the virus. A viral titre of
1 × 1010−11 TU/ml was used for stereotaxic injections and
downstream experiments.
Western Blots
Hippocampal neurons were isolated from E18 rats as described
previously (Shivaraj et al., 2012; Su et al., 2015). Dissociated
neurons were cultured on poly-L-lysine coated plates and
infected with lentivirus delivering shGSK3 or shCon the
following day. After 5 days, cell lysate was prepared in
radioimmunoprecipitation assay (RIPA) buffer (1% Triton X-
100, 50 mM HEPES, pH 7.0, 150 mM NaCl, 2 mM EGTA,
0.25% sodium deoxycholate, 0.2 mM phenylmethylsulfonyl
fluoride with phosphatase and protease inhibitors). For in vivo
quantification, both hippocampi were isolated 4 weeks post
stereotaxic injection and homogenized in RIPA buffer. Protein
concentration was measured and 20 µg of protein was separated
on an 8% SDS-PAGE gel and transferred to a polyvinylidene
fluoride (PVDF)membrane. Primary antibodies used were rabbit
anti-GSK3β antibody (Cell Signaling Technology, 1:5000) and
Mouse anti-alpha tubulin antibody (Sigma, 1:10000). Enhanced
chemiluminescence (ECL) horseradish peroxidase linked anti-
rabbit or anti-mouse antibodies (GE Healthcare) were used as
secondary antibodies. Restore PlusWestern Blot Stripping Buffer
(Thermo Scientific) was used for stripping purposes. SuperSignal
West Pico Chemiluminescent Substrate (Thermo Scientific) was
used to develop the blots. Histograms of all western blots were
checked during the capture process by the GE LAS4000 imaging
machine and also in image J. This is to ensure that all blots used
for quantifications are not overexposed. Quantification of band
intensities was done using image J.
Stereotaxic Injections
Stereotaxic surgical procedures were performed under deep
anesthesia (Ketamine 100 mg/ml, Xylazine 20 mg/ml) at a dose
of 85 mg of Ketamine and 10 mg Xylazine per kg of animal body
mass. Animals were mounted on a stereotaxic frame instruments
(Kopf Instruments, Tujunga, CA, USA). An incision was made
along the midline of the scalp and the skull exposed. Small burr
holes were drilled into the skull at the following coordinates
as previously described (Ge et al., 2006; Zhao et al., 2015): (1)
2 mm posterior to bregma, ±1.6 mm lateral to midline, 2.5 mm
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ventral from skull; (2) 3 mm posterior to bregma, ±2.6 mm
lateral to midline, 3.2 mm ventral from skull. Lentivirus was
injected using a 1 µl Hamilton syringe at a volume of 0.5 µl
per site (flow rate of 0.05 µl/15 s). 0.5% Bupivacaine was
administered after the surgery to provide acute pain relief. 1–5
mg/kg of Butorphanol was administered subcutaneously for 2
days after surgery to relief pain from the surgical procedure
and to ensure that animals experience little or no discomfort
after the surgery. Animals showing signs of pain and/or obvious
discomfort outside this time period were removed from the study
and euthanized.
Electrophysiology
Hippocampal slices of 12 wild type mice of 10–12 weeks of age
injected at 6–8 weeks old with shCon (six mice) or shGSK-3β (six
mice) were used (4 weeks after injection) for electrophysiological
recordings as previously described (Sajikumar et al., 2005).
Briefly after anesthetization using CO2, mice were decapitated
and the brains were quickly removed and cooled in 4◦C
artificial cerebrospinal fluid (ACSF). Transverse hippocampal
slices (400µm) were prepared from the right hippocampus using
a manual tissue chopper and the slices were incubated at 32◦C
in an interface chamber. The ACSF contained the following
(in mM): 124 NaCl, 4.9 KCl, 1.2 KH2PO4, 2.0 MgSO4, 2.0 CaCl2,
24.6 NaHCO3, 10 D-glucose, equilibrated with 95% O2–5% CO2
(32 L/h). Slices were preincubated for 2.5 h. Recordings in the DG
were performed similar to thatmethod described inWalther et al.
(1998) and Balschun et al. (1999). After the preincubation period,
a monopolar lacquer-coated, stainless-steel electrode (5MΩ; AM
Systems, United States of America) was placed in the stratum
moleculare of the DG to stimulate the medial performant path
input. About 200 µm apart, the recording electrode was lowered
to the same level to record field excitatory postsynaptic potentials
(fEPSPs). The stimulation strength was adjusted to elicit a fEPSP
slope of 40% of the maximum of the corresponding I/O curve.
Long-term potentiation (LTP) was induced by a repeated, 3-fold
tetanization paradigm consisting of 15 bursts of eight pulses,
200 Hz, interburst interval 200 ms, which were applied with an
interval of 10 min. The slopes of the fEPSPs were monitored and
the baseline was recorded for 30 min before LTP induction. Four
0.2-Hz biphasic constant-current pulses (0.1 ms/polarity) were
used for baseline recording.
Behavioral Tests
All behavioral tests were performed in an individual, dedicated
experimental room. On the testing day, animals were put in the
test room at least 20 min before testing in order to acclimatize.
The experimenter was always blind to the treatment type when
performing the tests.
Open Field Activity
Mice were placed in a 40 × 40 × 40 cm transparent Plexiglas
arena and allowed to explore freely for 10 min. Exploratory
activity was recorded with a TopScan behavior monitoring and
analysis system (CleverSys). Exploratory behavior in the middle
of the arena was determined by splitting the arena into 4 × 4
squares within the software and considering the middle 2 × 2
square as the middle of the arena.
Object Location Test
The experiment was performed and data analyzed as previously
described (Barker and Warburton, 2011). For the first 2 days,
mice were allowed to explore and habituate in a 40× 40× 40 cm
transparent Plexiglas arena for 10 min each day. On the third
day, mice were trained by placing them in the same arena with
two similar objects at different corners of the arena for 10 min.
After 24 h, the mice were placed in the same arena with identical
objects, with one of the object at a novel location and another
at a familiar location. Exploratory behavior was recorded with
a TopScan behavior monitoring and analysis system (CleverSys)
for 10 min and the amount of time a mouse spends exploring
an object was timed by hand. Object exploration was defined
as a nose poke within a 1 cm of the object. Object location
discrimination ratio was calculated by subtracting familiar object
exploration time from novel object exploration time and dividing
the difference by the total time spent exploring both objects.
Morris Water Maze
The water maze consisted of a 120 cm diameter gray circular pool
filled with water (23–26◦C, 40 cm deep) made opaque by adding
non-toxic white paint (Crayola®). The pool was surrounded by
several distant cues from the environment of the experimental
room. The animals learned to find a transparent platform (10 cm
in diameter) hidden 1 cm below the water surface, and which
location remained constant throughout the experiment. Each
animal was tested four times a day at five consecutive days,
with an inter-trial of about 20 min. For each day, mice were
systematically weighted before the first trial then released facing
the tank wall from one randomly selected starting points (North,
South, East or West), and allowed to swim until they reached
the platform. Animals that failed to find the platform within
60 s were gently directed to it and put on it for 15 s. After
the trial, mice were removed from the pool, gently dried with
a towel and placed individually in cage filled with paper towel
and warmed with water bottles placed under the cages to avoid
hypothermia. The criterion of learning success consisted to reach
the platform in less than 20 s. On the 6th day, a 60 s probe
trial was conducted without platform and the time spent in each
quadrant was analyzed. This trial was followed by a 60 s cued
test to check the visual acuity of the mice. Trials were recorded
with a video camera placed above the center of the pool and the
quantitative analysis was automated by means of the ANY-maze®
video tracking system (Stoelting, USA).
Fear Conditioning
All fear training was performed in a set of four identical fear-
conditioning chambers (Med Associates), equipped with a Med
Associates Video Freeze system. Individual boxes were enclosed
in sound-attenuating chambers (Med Associates). The grid floor
consisted of stainless steel rods. Chambers were individually
lit from above with white house lights and cleaned with 70%
isopropyl alcohol in between squads. On the day of training
mice were placed into individual experimental chambers set up
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to conditioning context A which consisted of a bare chamber
with white walls, steel rod floor, undiffused white house lights,
and lightly scented with Septanol (ICM Pharma). Following
a 180 s baseline period of exposure to the context A, mice
were fear conditioned using a 30 s, 5000 Hz, 90 dB tone co-
terminating with a 0.7 mA, 2 s foot shock. Following the shock,
mice were given 120 additional seconds in the same context
before being removed. Contextual fear memory retrieval was
assessed 24 h later by placing mice back into the same context
for a 5 min exposure session. Cue fear memory retrieval was
performed 1 h after contextual fear retrieval. The environment
was changed to context B consisting of a smooth white floor,
diffused white lighting, walls of a different texture and color, and
the chamber scented with a different scent. Mice were exposed
to the new context for 120 s before being exposed to a 30 s,
5000 Hz, 90 dB tone. Mice were further monitored for freezing
activity for another 4.5 min before being returned to their home
cages. For fear acquisition, average freezing after foot shock
administration was scored and analyzed. For contextual memory
test, freezing across the first 3 min of context exposure A was
scored. For cue fear memory, freezing activity in the context
B for 5 min from the presentation of the tone was scored and
analyzed.
Perfusion and Sectioning
Mice were deeply anesthetized with pentobarbital and
transcardially perfused with chilled physiological saline followed
by 4% paraformaldehyde in PBS. Extracted mice brains were
post fixed in the same buffer for 8 h before being transferred to
30% sucrose solution and stored at 4◦C. Fixed mice brains were
sliced with a sliding microtome (Leica) to obtain 40 µm-thick
coronal sections. Slices containing hippocampus were collected
at every 6th interval in an anterior to posterior manner and used
for downstream experiments.
5-ethynyl-2′-deoxyuridine (EdU) Cell Counting
within the DG
Animals were injected with 100 µg of EdU on the day of
lentiviral injection. Animals were sacrificed after 28 days.
Brain sections were stained for EdU with Click-iT EdU Alexa
Fluor 647 kit (Invitrogen) and 4′,6-diamidino-2-phenylindole
(DAPI; Invitrogen) according to manufacturer’s instructions.
Sections were imaged with a Zeiss LSM710 Laser scanning
confocal microscope. Total number of EdU positive cells within
the granular layer and the area of the granular layer was
quantified for each section. Granular layer volume is calculated
by multiplying the total area by 40 µm which is the thickness of
each section and by 6 which is the sectioning interval between
each collected section. Total density of EdU positive cells in
the granular layer was calculated by dividing the total EdU cell
number by volume of the granular layer.
Immunohistochemistry
The following primary antibodies were used to immuno-stain
brain sections: goat anti-doublecortin (Santa Cruz, 1:500), mouse
anti-NeuN (Milipore, clone A60, 1:500), rabbit anti-GSK3β (Cell
Signaling Technology, 1:200). Brain sections were blocked in 5%
donkey serum in tris-buffered saline (TBS) and 0.1% Triton-X
for 1 h. Brain sections were incubated with primary antibodies
at 4◦C overnight. Appropriate Alexa Fluor 555 or 647 antibodies
(Invitrogen, 1:500) were incubated with the brain slices for 2 h
at room temperature. Further staining with Click-it EdU Alexa
Fluor 647 kit (invitrogen) and DAPI (Invitrogen) was performed
if needed. Brain sections were then cover slipped and kept at 4◦C
in a light proof box.
Statistics
Data were statistically analyzed using Student’s-T-test unless
otherwise stated. The average values of the slope function of the
field EPSP (in millivolts per millisecond) per time point were
subjected to statistical analysis using the Wilcoxon signed rank
test when compared within one group; p < 0.05 was considered
as statistically significant different.
Results
Lentivirus Delivers shRNA to Cells in the
Granular Layer and Hilus of the DG
We first examined the delivery efficiency of lentivirus
carrying shRNA constructs by injecting lentivirus constructs
coding for shRNA against either GSK3β (shGSK3) or
shRNA with scrambled sequence (shCon) (Figure 1A)
into the DG of young adult mice. Green fluorescence
protein (GFP) expression was detected in cells within
the granular layer and the hilus of the DG at both sides
of the brains 28 days post injection (Figure 1B). Axons
and dendrites from GFP labeled cells within the granular
layer are clearly visible and extend towards the CA3 region
through mossy fiber and towards molecular layer respectively
(Figure 1B).
Previous literature has suggested that the inhibition of
GSK3β is able to promote neurogenesis in vitro and in
vivo (Morales-Garcia et al., 2012). To explore if neurogenesis
was impacted in our knockdown model, EdU was injected
on the same day as lentiviral injections. A quantification of
EdU-positive cells within the DG granular layer showed no
statistically significant difference between shCon and shGSK3
groups (Figure 1C). DG GSK3β silencing in our mice model
thus, has no significant impact on neural progenitor cell
proliferation within the DG. We next determined if our
lentivirus has a preference to infect progenitor cells or granular
layer neurons in immature or mature stages of development.
Fluorescence imaging on brain slices from mice 10 days post
injection showed that subpopulations of GFP expressing cells
for both constructs expressed the immature neuronal marker
doublecortin (DCX; Figure 1D), or the mature neuronal marker
NeuN (Figure 1D), and can be labeled with EdU (Figure 1E).
We show here that there are many NeuN positive cells, lesser
DCX positive cells and very few EdU infected cells, which
corresponds to the typical cell composition in the DG. Our
lentivirus is thus able to infect and deliver short hairpin
constructs into dividing cells and neurons at various phases of
development without any significant preferences for any specific
cell types.
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FIGURE 1 | Efficiency of lentivirus infection in dentate gyrus (DG) of
injected brains. (A) Schematic diagram showing knockdown (KD)
lentiviral construct with shRNA expression driven by U6 promoter and
GFP expression driven by ubiquitin C promoter. (B) Representative image
showing typical infection efficiency of KD lentivirus in DG in both sides of
the brain. Insets in white box and yellow box are high magnification
images of dendrites and axons of lentivirus-infected cells, demonstrating
dendrites projecting to molecular layer and axons projecting through
mossy fibers to CA3 region respectively. (C) Graph showing number of
EdU+ cells per area (108 µm3) of DG granular cell tissue at 28 days
post injection (n = 3 animals per group) (error bars shown represented
SEM). (D,E) Representative images showing GFP expression in granular
cells co-expressing DCX (immature neuronal marker), NeuN (mature
neuronal marker) and cells labeled with EdU (proliferating cells) at 10
days post injection. EdU was injected on the same day as virus injection.
Scale bar = 200 µm for (B) or 10 µm for inset in (B) and for (D,E).
shRNA against GSK3β Reduced GSK3β Protein
Levels but has no Impact on Hippocampal
Neurogenesis
We next sought to determine the efficiency of our shGSKβ in
reducing GSK3β protein levels in vitro and in vivo. Lentiviruses
carrying shCon or shGSK3 were used to infect cultured rat
primary cortical neurons. shGSK3, but not shCon was able
to reduce the expression of GSK3β in these cultured neurons
(Figure 2A). To validate the knockdown of GSK3β in vivo,
mice injected with virus were sacrificed 28 days post lentiviral
injections. Whole hippocampal extracts showed significantly
lower levels of GSK3β (Figures 2B,C), P = 0.0003. To further
verify the efficiency of GSK3β knockdown in individual cells
in the DG, brains were sectioned and immuno-stained for
GSK3β. Cells infected with lentivirus expressing shGSK3 showed
lower levels of GSK3β fluorescence intensity in the cytoplasm as
compared to those expressing shCon (Figures 2D,E). Thus, our
shGSK3 construct efficiently reduced GSK3β protein levels both
in vitro and in vivo.
Silencing of GSK3β in the DG has no Significant
Effect on Locomotor Activity or Anxiety-Like
Behavior
GSK3β has been implicated in hyperactivity and anxiety (Polter
et al., 2010). Differences in locomotor activity or anxiety between
mice groups may confound results in behavioral tests that assess
learning and memory. To determine if there are differences in
locomotor or anxiety-like behavior levels between shCon and
shGSK3 mice, mice were monitored in an open field 4 weeks
after injection (28 DPI). No significant differences in distance
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FIGURE 2 | Efficiency of lentivirus carrying shRNA in knocking
down GSK3β. (A) Representative western blot of GSK3β in primary
cortical neurons infected with lentivirus expressing shCon or shGSK.
(B) Representative western blot of GSK3β from whole hippocampal
extracts of three shCon and four shGSK3-injected mice. (C)
Quantification of GSK3β protein levels from whole hippocampal extracts
of shCon and shGSK3-injected mice. (D) Representative images showing
immunostaining against GSK3β in shCon or shGSK3 expressing cells in
DG. (E) Graph showing quantification of GSK3β fluorescence intensity in
the cytoplasm of cells expressing shGSK3β as compared to those
expressing shCon. Error bars shown represented SEM. Student’s-T-test
***P < 0.001, Scale bar = 10 µm.
traveled were found between groups (Figure 3A). The percentage
time whereby a mouse spends in the middle of the open field
has been used as a measure of anxiety (Ramboz et al., 1998).
Both groups showed similar times spent in the middle of the
open field. (Figure 3B) Silencing of GSK3β in the DG therefore
did not significantly impact locomotor activity and anxiety-like
behavior.
Silencing of GSK3β in the DG has no Significant
Effect on Acquisition and Retrieval of Long-term
Spatial Memory
To assess if silencing of GSK3β in the DG will affect spatial
learning and memory in healthy mice, two hippocampus-
dependent spatial memory tasks were used, namely the spatial
object location task (experimental design summarized in
Figure 3C) and the Morris Water Maze. During the test phase of
the spatial object location task, both groups of mice spent more
time exploring the object in the novel location as represented
by the positive discrimination ratios. The discrimination ratios
in our study were in line with other studies showing learning
in the object location task (Ennaceur et al., 1997; Kesby et al.,
2015). However there were no significant differences between the
discrimination ratios of both control and GSK3β-silenced mice
(Figure 3D).
To validate our object location test results, a Morris water
maze-based analysis was performed. With repeated training,
both groups showed a similar decrease in time and swim distance
required to locate the hidden platform (Figures 4A,B). During
the probe trial, both groups spent significantly more time in the
FIGURE 3 | Silencing of GSK3β in DG does not affect locomotor
activity, anxiety-like behavior and object discrimination. (A) Graph
shows open field activity of shCon or shGSK3β lentivirus-injected mice.
(shCon: n = 12, shGSK3: n = 15 mice) (B) Graph shows amount of time spent
by both groups of mice in the middle of the open field arena. (C) Illustrations
showing object location training and test procedure. (D) Graph shows object
location discrimination between both groups of mice. (shCon: n = 12,
shGSK3: n = 9 mice, error bars are SEM).
quadrant where the platform was previously located as compared
to the opposite quadrant (Figure 4C). The number of entries in
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FIGURE 4 | Knocking down of GSK3β does not affect spatial
memory in Morris water maze. (A) Graph shows average time needed
for both shCon or shGSK3β lentivirus-injected mice to find hidden
platform for each day of training (with four trials per day pooled). (B)
Graph shows average distance swum by each group of mice to find
hidden platform for each day of training. (C) Graph shows time spent
exploring each quadrant during the probe trial (shCon: n = 11 shGSK3:
n = 10, *p < 0.05, ***p < 0.001, error bars are SEM, ANOVA followed
by Bonferroni Post hoc comparisons). (D) Graphs shows number of
entries into platform area by both groups of mice during the probe trial.
the area where the platform was similar in both groups as well
(Figure 4D). Together these results suggest that spatial learning
and memory is not significantly affected in our DG GSK3β-
silenced mice.
GSK3β Silencing Impairs Contextual Fear
Memory
In addition to spatial memory, the hippocampus is also involved
in contextual memory consolidation. To assess if GSK3β
silencing has an effect on contextual memory, we examined
mice using a contextual fear-conditioning task (Figure 5A).
During the habituation phase of training, both groups showed
negligible freezing times. After exposure to a 30 s tone and
2 s shock, both groups showed significantly increased freezing
indicating the acquisition of contextual fearmemory (Figure 5B).
After 24 h, both groups were assessed for the retrieval of
contextual fear memory. The GSK3β-silenced group showed
significantly lower freezing times as compared to control (p =
0.0004), indicating an impairment in contextual fear memory
(Figure 5C). As the amygdala is well known to contribute
towards contextual fear memory, we performed an amygdala-
dependent, hippocampus-independent cued fear memory test
to assess amygdala function. After exposure to the cue in
a novel environment, both groups of mice showed similar
levels of increased freezing (Figure 5D). The impairment in
contextual fear memory formation observed in DG GSK3β
silenced mice was therefore due to defective consolidation by the
hippocampus.
GSK3β Silencing Increases LTP
To investigate if the contextual fear memory impairment
observed in shGSK3 mice may be due to changes in synaptic
plasticity, we performed LTP recordings on brain slices from
naïve mice harvested 28 days post lentiviral injection. LTP was
induced in both groups, and both groups showed maintenance
of late LTP (Figures 6A,B). However, shGSK3 mice showed
a much higher level of LTP upon induction as compared to
control. This difference in LTP level between the groups persisted
throughout the recording period of 60 min. Figure 6A showed
statistically significant potentiation compared to its own base
line (−15 min) after LTP induction (+15 min and +60 min, p
= 0.0010 in both cases, Wilcoxon Sign Rank test). Similarly, post
tetanic potentials at +15 min and +60 min in Figure 6B was also
significantly higher compared to its own baseline (p = 0.0005 in
both cases, Wilcoxon Sign Rank test). A comparison between
the LTP from DG of control and shGSK3 mice (Figures 6C,D)
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FIGURE 5 | Knocking down of GSK3β affects contextual memeory. (A)
Schematic diagram shows habituation and test procedures for contextual fear
memory test. (B) Graph shows percentage of freezing time during various
phases of fear training. (C) Graph shows percentage of time freezing across
3 min when mice were placed back in the fear chamber 24 h after training
(Student’s-T-test ***p < 0.001). (D) Graphs shows percentage of time freezing
when mice were placed in a contextually different chamber but presented with
an identical tone (shCon: n = 25, shGSK3: n = 14, error bars SEM).
also revealed statistically significant potentiation in DG-LTP in
shGSK3 compared to control mice (p = 0.0005 and p = 0.0006
respectively at +15 and +60 min, MannWhitney U Test).
Discussion
Previous studies examining the cognitive effects of GSK3β
manipulation have typically used transgenic or pharmacological
inhibitor animal models. However, functional dissection of a
multi-functional protein kinase such as GSK3β with differing
roles in the developing and adult brain (Salcedo-Tello et al., 2011)
or in different tissues in the body (Patel et al., 2008) will require a
more targeted approach. To our knowledge, our study is the first
to assess the cognitive effects of long term GSK3β silencing in the
DG of mice during young adulthood.
Long term gene knockdown with the use of lentiviral vectors
delivering shRNA has been successfully performed previously
(Abbas-Terki et al., 2002). Our lentiviral-mediated delivery of
shRNA against GSK3β into the mouse DG was to reduce GSK3β
levels within DG granule cells. In our study, whole hippocampal
GSK3β protein levels showed a modest but significant reduction
of GSK3β. This modest reduction is likely due to diluting effects
from the surrounding non-transduced tissue within and around
the DG. Nonetheless, our knockdown was sufficient to elicit
behavioral and electrophysiological differences between both
groups of animals.
Cells infected by our lentivirus included dividing cells and
neurons at various stages of maturation; both of which are known
to play important roles in hippocampus-dependent learning and
memory (Saxe et al., 2006; Deng et al., 2009; Gu et al., 2012;
Nakashiba et al., 2012; Vukovic et al., 2013).
Overexpression or knock-in studies where GSK3β activity
is significantly higher than physiological levels have resulted
in decreased neurogenesis (Eom and Jope, 2009; Sirerol-Piquer
et al., 2011). In neurocognitive disorders such as Down syndrome
and Fragile X where neurogenesis is impaired, administration
of GSK3β inhibitors were shown to enhance neurogenesis (Guo
et al., 2012; Contestabile et al., 2013). The effects of GSK3β
inhibition on neurogenesis in healthy adult mice are not as clear.
Several studies utilizing various GSK3β inhibitors showed an
increase in adult neurogenesis (Boku et al., 2009; Eom and Jope,
2009; Morales-Garcia et al., 2012), while a study using valproic
acid (Sintoni et al., 2013) did not find any significant changes.
The differences in observations may be due to differences
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FIGURE 6 | Time course of DG-LTP in mice expressing shCon or
shGSK3 in DG. (A,B) After recording a stable baseline of 30 min, three
times TBS was applied within an interval of 10 min (3 × TBS) which
resulted in lasting potentiation up to 60 min. shGSK3 group (n = 12)
(B) showed higher potentiation compared to control group (n = 11) (A).
(C) Graph shows merged control and shGSK3 LTP for direct comparison.
(D) The bar graph represents the difference in the percentage of
potentiation at −15, 15 and at 60 min after the induction of LTP in control
(open bar) and shGSK3 (filled bar). The asterisks in 15 and 60 min
represent statistically significant potentiation (Mann Whitney U Test *p <
0.005) in shGSK3 group as compared to the shCon group. Triple arrow
represents TBS applied for inducing LTP. Error bars represent SEM.
between drugs, dosage and types of cells or animal models
used. We found that shRNA-mediated silencing of GSK3β did
not significantly change cell proliferation levels within the DG,
suggesting that it is unlikely that the behavioral phenotypes
we observed are due to the potential effect of cell-autonomous
GSK3β silencing on cell proliferation.
We found silencing of GSK3β in the DG particularly impacted
long-term contextual fear memory retrieval but not that of long-
term spatial memory. Although the DG is involved in both
contextual and spatial memory, both types of memory have been
shown to involve different molecular and neural pathways (Bach
et al., 1995; Mizuno and Giese, 2005). Contextual fear memory
has been shown to be disrupted by lesions of the entorhinal
cortex while spatial memory was not affected (Burwell et al.,
2004). The DG receives inputs from the entorhinal cortex via
the perforant path (Lomo, 1971) and overexpression of GSK3β
impairs LTP recorded from the CA3 or DG upon stimulation
of the perforant path (Hooper et al., 2007; Zhu et al., 2007).
Therefore, it is possible that GSK3β in the DG may have a
role in the processing of inputs from the perforant pathway.
The lack of spatial memory impairment observed in our study
may imply that the reduction of GSK3β levels in the healthy
DG does not negatively impact spatial memory or the level of
viral-mediated GSK3β silencing in our study is insufficient to
elicit spatial memory impairment. Previous lesion studies have
shown that spatial memory remains intact evenwhen only a small
portion of the dorsal hippocampus is left unlesioned (Moser
et al., 1995).
Two forms of synaptic plasticity, LTP and long term
depression (LTD) are generally accepted models of information
storage within the hippocampus and have been considered
as cellular correlates of learning and memory (Bliss and
Collingridge, 1993; Bear and Abraham, 1996). LTP can be
further divided into two phases; early LTP is associated with
changes in trafficking and conductance of receptors at the
surface of synapses while late LTP is associated with protein
expression and synaptic remodeling (Abraham and Williams,
2008). GSK3β has previously been found to be implicated
in cellular processes related to synaptic plasticity such as α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
(AMPAR) trafficking (Du et al., 2010; Wei et al., 2010; Xie
et al., 2011; Nelson et al., 2013), N-methyl-D-aspartate receptor
(NMDAR) trafficking (Chen et al., 2007; Zhu et al., 2007;
Peineau et al., 2009), GABAA surface receptor expression (Rui
et al., 2013), pre-synaptic vesicle trafficking (Zhu et al., 2007,
2010), transcription of immediate early genes (IEGs; Graef
et al., 1999), and transcription of genes required for L-LTP
(Ma et al., 2011). Previous recordings from the CA1 region of
the hippocampus have shown that GSK3β activity is decreased
during the induction of LTP and increased during the induction
of LTD (Hooper et al., 2007; Peineau et al., 2007). Subsequent
pharmacological and genetic manipulations have shown that
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regulation of GSK3β activity is pivotal for the switch between
LTP and LTD. Overactive GSK3β prevents the induction of LTP
(Hooper et al., 2007; Zhu et al., 2007; Dewachter et al., 2009),
while inhibition of GSK3β prevents the induction of LTD but
allows LTP induction (Peineau et al., 2007, 2009; Xie et al.,
2011). Induction of LTP has also been shown to inhibit GSK3β
activity and prevent subsequent induction of LTD for up to an
hour (Peineau et al., 2007). Our finding that long term GSK3β
silencing enables induction of persistently higher LTP supports
the findings of a study which showed that pharmacological
inhibition of GSK3β with 10 mM LiCl for 60 min prior to high
frequency stimulation (HFS) is able to enhance induction of LTP
in the CA1 region (Cai et al., 2008). However, another study
involving pharmacological inhibition of GSK3βwith 20mMLiCl
or 2 µM CT99021 for 30 min prior to HFS showed no increase
in DG-LTP in wild type animals (Franklin et al., 2014). It is
possible that the shorter incubation period prior to HFS may
not be sufficient to elicit a difference in DG-LTP for wild type
animals.
The enhancement of LTP in the DG has been shown to play
functionally differing roles from the CA1 region and can result in
memory impairments (Okada et al., 2003). Our observation that
LTP is enhanced in theDGof GSK3β silencedmicemay therefore
potentially correlate with the contextual fear memory deficits
observed. This enhanced LTP but decreased in memory retrieval
is consistent with studies reporting dissociation in hippocampal
LTP and associative learning in mice (Sahún et al., 2007; Gruart
et al., 2012). Although hippocampus is involved in associative
learning, the contribution of different synapses is still poorly
understood. Recent findings that reported differences in the
functional aspects of different synapses within the hippocampus
suggested that evolution of the timed changes in synaptic
strength during functional organization did not coincide with
the sequential distribution with respect to anatomical criteria
and connectivity (Gruart et al., 2014). Moreover, hippocampal
intrinsic and extrinsic circuits are involved in acquisition of cue
and context information during associative learning (Carretero-
Guillén et al., 2015). Future studies can explore the effects
of GSK3β silencing on cellular processes related to synaptic
efficiency in specific cell population such as adult DG granule
cells.
Administration of GSK3β inhibitors to healthy individuals
have resulted in impairments in cognitive performance
(Weingartner et al., 1985; Stip et al., 2000;Wingo et al., 2009).We
believe a targeted approach will decrease potential detrimental
side effects when GSK3β activity is manipulated for therapy
or prophylaxis. Our study is the first step in such a direction
and future work will involve manipulating GSK3β activity in
different brain regions at different developmental stages to better
understand the role of GSK3β in learning and memory.
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